HIGHGATE GROUP PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: F85014 | LONDON, N6 4QA
Showing results 351-400 of 621
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Amisulpride | 50 | 894 | £363 | -28.9% ▼ |
| Gamolenic acid | 50 | 2,304 | £424 | +384.2% ▲ |
| Diphtheria | 50 | 50 | £360 | -25.1% ▼ |
| Domperidone | 49 | 6,652 | £321 | +37.4% ▲ |
| Bicalutamide | 49 | 1,092 | £103 | +51.5% ▲ |
| Brinzolamide and timolol | 49 | 760 | £986 | +29.6% ▲ |
| Naldemedine | 48 | 336 | £481 | +446.5% ▲ |
| Ranolazine | 48 | 6,000 | £1.1K | -71.8% ▼ |
| Powder extensively hydrolysed formula (0913101) | 48 | 155.2K | £4.4K | -33.4% ▼ |
| 48 | 630 | £1.1K | +46.2% ▲ | |
| Metronidazole | 46 | 1,905 | £823 | +22.4% ▲ |
| Duloxetine hydrochloride | 45 | 3,556 | £766 | -12.2% ▼ |
| Benzydamine hydrochloride | 45 | 14.1K | £260 | -41.8% ▼ |
| Naloxegol | 44 | 568 | £998 | +219.0% ▲ |
| 44 | 6,480 | £325 | -66.4% ▼ | |
| Prucalopride | 43 | 3,430 | £1.6K | +10.4% ▲ |
| Ticagrelor | 43 | 4,956 | £4.8K | -49.4% ▼ |
| Hyoscine hydrobromide | 43 | 944 | £155 | +25.9% ▲ |
| Anastrozole | 43 | 3,360 | £127 | -52.8% ▼ |
| 43 | 2,770 | £5.8K | +27.3% ▲ | |
| Lacosamide | 42 | 11.0K | £1.7K | -21.8% ▼ |
| Tirzepatide | 42 | 89 | £8.9K | -78.4% ▼ |
| Haloperidol | 41 | 1,776 | £6.1K | -13.9% ▼ |
| Alprostadil | 41 | 200 | £2.2K | +139.7% ▲ |
| Coal tar | 41 | 10.7K | £256 | -43.7% ▼ |
| 40 | 136 | £445 | -1.7% vs avg | |
| 40 | 475 | £154 | -80.9% ▼ | |
| Daridorexant | 39 | 608 | £812 | +198.4% ▲ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 39 | 343.5K | £3.1K | -35.8% ▼ |
| Chlorhexidine gluconate | 39 | 19.1K | £338 | +32.1% ▲ |
| 39 | 581 | £1.4K | -0.9% vs avg | |
| 39 | 2,220 | £8.4K | +50.8% ▲ | |
| Dulaglutide | 38 | 396 | £7.3K | -66.8% ▼ |
| Cinacalcet hydrochloride | 38 | 896 | £237 | +63.8% ▲ |
| Calcium acetate/magnesium carbonate | 38 | 798 | £105 | +114.5% ▲ |
| Pimecrolimus | 38 | 1,720 | £1.0K | +124.4% ▲ |
| 38 | 707 | £694 | +17.4% ▲ | |
| 38 | 406 | £91 | +1.1% vs avg | |
| 38 | 3,706 | £7.1K | -4.7% ▼ | |
| 38 | 113 | £918 | +36.6% ▲ | |
| 38 | 51 | £8.2K | +6.4% ▲ | |
| 37 | 1,332 | £804 | -46.0% ▼ | |
| 37 | 4,640 | £288 | -82.9% ▼ | |
| Valaciclovir | 36 | 2,538 | £3.1K | +156.2% ▲ |
| Sulfasalazine | 35 | 8,096 | £3.0K | -73.1% ▼ |
| Bezafibrate | 35 | 2,462 | £481 | -35.0% ▼ |
| Biphasic insulin aspart | 35 | 350 | £2.1K | -65.5% ▼ |
| Water for injection | 35 | 590 | £210 | +3.5% ▲ |
| 35 | 94 | £711 | +12.8% ▲ | |
| Pizotifen malate | 34 | 5,516 | £230 | -58.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.